(Image: Junaid A. Syed, M.D.) ISSCA President Daeyong Kim, Ph.D., has named Junaid Sayed, M.D. president of ISSCA’s U.S. chapter. MIAMI, Jan. 18, 2018—International Society for Stem Cell Application (ISSCA) President Daeyong Kim, Ph.D., has named Junaid Sayed, M.D. president of ISSCA’s U.S. chapter. Sayed is Board Certified physician with extensive
MIAMI, Jan. 15, 2018—Global Stem Cells Group (GSCG) subsidiary Stem Cell Center Network, the world’s largest collective support and advisory network of regenerative medicine clinics and physicians, has announced the opening a new facility in San Jose, Puerto Rico in January 2018. Stem Cell Center Puerto Rico will
ISSCA will conduct the next regenerative medicine certification training course in Mexico City, Feb. 9-10, 2018. The two-day course focuses on harvesting adipose and bone marrow stem cells from patients in a clinical environment. MIAMI, Jan. 15, 2018—The International Society for Stem Cell Application (ISSCA) announced plans to hold
ISSCA has announced plans to launch the first bilingual (English and Spanish) regenerative medicine newsletter. MIAMI, Jan. 15, 2018—The International Society for Stem Cell Application (ISSCA) will launch the first bilingual (English and Spanish) regenerative medicine newsletter January 23, 2018. The monthly newsletter will be available for free to
ISSCA has announced its sponsorship of XXVI Jornadas Mediteraneas – Mediterranean Days of Therapeutic Confrontations in Medicine and Cosmetic Surgery to be held in Barcelona, Spain May 11 – 13, 2018. ISSCA has committed to sponsoring the event for five consecutive years. MIAMI, Jan. 15, 2018—The International Society for Stem Cell Application (ISSCA) has announced
MIAMI, Jan. 15, 2018 – Global Stem Cells Group, a world leader in stem cell and regenerative medicine, will host its South American Regenerative Medicine Symposium August 23, 24, and 25th in Buenos Aires, Argentina. This will be GSCG’s fifth consecutive year hosting the symposium. The main topic for
Image: Benito Novas Global Stem Cells Group founder and CEO Benito Novas was recognized as a leader in regenerative medicine at the XVIII International Congress of Aesthetic Medicine, Aesthetic Surgery and Obesity, Dec. 2, 2017, in Mexico City. MIAMI, Dec. 22, 2017—Benito Novas, founder and CEO of Global Stem
Adimarket, a subsidiary of Global Stem Cells Group, has announced an agreement with biotechnology company Alolotl Biologix to distribute biological products for regenerative medicine applications worldwide. MIAMI, Dec.21, 2017— Adimarket, a subsidiary of Global Stem Cells Group (GSCG), and its subsidiary has announced an agreement with Phoenix, Arizona-based
Image: CIMA Hospital in Escazú Global Stem Cells Group announces plans to expand its Stem Cell Center Network to include a new stem cell treatment center in Escazú, Costa Rica. MIAMI, Dec. 21, 2017—Global Stem Cells Group (GSCG), a world leader in stem cell and regenerative medicine, has announced the
Global Stem Cells Group Research Director Martiza Novas Recognized for Her Work in Regenerative Medicine MIAMI, Dec. 22, 2017—Maritza Novas Research Director, Global Stem Cells Group, earned recognition for her work and achievements in regenerative medicine at the XVIII International Congress of Aesthetic Medicine, Aesthetic Surgery and Obesity, Dec. 2, 2017, in Mexico City. Novas
Global Stem Cells Group has announced the relaunch of its StemData cloud-based electronic medical record system specifically designed for regenerative medicine practitioners. MIAMI, Nov. 29, 2017—Global Stem Cells Group, a world leader in stem cell and regenerative medicine, has announced the relaunch of its StemData software, the first cloud-based electronic medical record system specifically designed
The International Association for Stem Cell Application moved to a new office at Piedra 383 at Ciudad Autonoma of Buenos Aires, Argentina. The move accommodates ISSCA’s increasing specialty and patient volume, as well as its expanding regenerative medicine certification training programs. MIAMI, Nov. 29, 2017—The International Association for Stem Cell Application (ISSCA) has announced the